综合报道

先天性甲状腺功能减低症筛查及治疗效果分析

  • 王秀利 ,
  • 彭磊 ,
  • 杨丹艳 ,
  • 武娇
展开
  • 徐州市妇幼保健所新生儿疾病筛查中心(江苏徐州 221009)

收稿日期: 2016-08-15

  网络出版日期: 2016-08-15

Analysis of screening and therapeutic effect of congenital hypothyroidism

  • WANG Xiuli ,
  • PENG Lei ,
  • YANG Danyan ,
  • WU Jiao
Expand
  • Neonatal Disease Screening Center, Xuzhou Maternity and Child Health Care Institute, Xuzhou 221009, Jiangsu, China

Received date: 2016-08-15

  Online published: 2016-08-15

摘要

 目的 了解先天性甲状腺功能减低症(CH)的筛查及替代治疗结果。方法 回顾性分析2003年7月—2015 年7月采用时间分辨荧光免疫法测定新生儿促甲状腺激素(TSH)水平筛查CH的资料;阳性召回的可疑患儿采用化学免 疫发光法测定血清甲状腺功能,确诊者予左旋甲状腺素钠替代治疗并定期随访。结果 12年来共筛查新生儿1 228 289例, 确诊950例,CH发病率1/1 293。接受正规治疗、随访满2年及以上的635例CH患儿中,488例(76.85%)为永久性CH, 147例(23.15%)为暂时性CH。CH患儿随访至1岁和3岁时,体格生长和发育商(DQ)无异常。结论 新生儿筛查可早期 诊断CH,早期实施替代治疗。

本文引用格式

王秀利 , 彭磊 , 杨丹艳 , 武娇 . 先天性甲状腺功能减低症筛查及治疗效果分析[J]. 临床儿科杂志, 2016 , 34(8) : 602 . DOI: 10.3969/j.issn.1000-3606.2016.08.010

Abstract

Objective  To explore neonatal screening and therapeutic effects of congenital hypothyroidism (CH)  in Xuzhou. Methods Data of  neonatal heel blood thyroid stimulating hormone (TSH) tested with time-resolved  fluoroimmunoassay from July 2003 to July 2015 were retrospectively analyzed; The cases with positive screening tests were  called back for further examination of the serum thyroid function (TSH,FT3,FT4) by chemiluminescence immunoassay method.  The CH patients were given levothyroxine replacement. A total of 686 patients with CH treated routinely for 1 years later (CH  group) and 650 matched healthy children (control group) were included in the study. The physical development was monitored  regularly. The neurodevelopment was tested at 1 and 3 years old. Results In Xuzhou 1228289 neonates were screened during  12 years,of them 950 cases were diagnosed with CH and the incidence was 1/1293. Among 635 CH patients who received  treatment and follow-up regularly for 2 years,?488 cases (76.85%) were evaluated to have permanent hypothyroidism and 147  cases (23.15%) have transient hypothyroidism. There were no significant differences in developmental quotient between the CH  group and the control group at 1 and 3 years old (P?>?0.05). Conclusions Neonatal disease screening is an effective measure  for early diagnosis of CH; the physical and mental development are normal in CH patients after early replacement therapy.
文章导航

/